Company Name | ·¬ÇÑÓ°ÊÓ. |
---|---|
Date Established | December 6, 1941 |
Head Office | 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan |
Telephone | 81-3-3817-3700 |
Representatives | Haruo Naito, Representative Corporate Officer and CEO
Yasushi Okada, Representative Corporate Officer and COO |
Capital | 44,986 million Yen (as of March 31, 2024) |
Scope of Business | Research and development, manufacture, sale and import and export of pharmaceuticals |
Organization Chart | |
Employees | Consolidated : 11,067
Non-Consolidated : 2,984 (as of March 31, 2024) |
Production Plants | Kawashima Industrial Park (Gifu Prefecture)
Kashima Plant (Ibaraki Prefecture) ·¬ÇÑÓ°ÊÓ Manufacturing Ltd. (U.K.) ·¬ÇÑÓ°ÊÓ China Inc. Suzhou Plant (China) ·¬ÇÑÓ°ÊÓ (Liaoning) Pharmaceutical Co., Ltd. Benxi Plant (China) ·¬ÇÑÓ°ÊÓ Pharmaceuticals India Pvt. Ltd. (India), etc. |
Laboratories | Tsukuba Research Laboratories (Ibaraki Prefecture)
Kawashima Industrial Park (Gifu Prefecture) Kashima Business Office (Ibaraki Prefecture) Kobe Research Laboratories (Hyogo Prefecture) ·¬ÇÑÓ°ÊÓ Center for Genetics Guided Dementia Discovery (G2D2) (U.S.A.) Exton Site (U.S.A.) Hatfield Research Institute (U.K.), etc. |
Overseas Sales Offices | ·¬ÇÑÓ°ÊÓ Inc. (U.S.A.)
·¬ÇÑÓ°ÊÓ Ltd. (U.K.) ·¬ÇÑÓ°ÊÓ GmbH (Germany) ·¬ÇÑÓ°ÊÓ S.A.S. (France) ·¬ÇÑÓ°ÊÓ China Inc. (China) ·¬ÇÑÓ°ÊÓ Korea Inc. (South Korea), etc. |
Stock Information
Fiscal Year End | March 31 |
---|---|
Record Date for Dividend | Year-end dividend - March 31
Interim dividend - September 30 |
Annual Shareholders' Meeting | June |
Stock Exchange Listings | Tokyo Stock Exchange |
Stock Trading Unit | 100 shares |
Ticker Code | 4523 |